Gül Erdemli
Company: Novartis AG
Job title: Global Program Regulatory Director
Seminars:
Developing Novel Digital Measures for Neurodegenerative Diseases 11:30 am
Incorporating functional and mobility performance assessments in Alzheimer’s and Parkinson’s populations Highlighting the potential of digital measures to capture patient experiences in real-world settings Outlining feedback from regulatory agencies about how these endpoints can be further developedRead more
day: Conference Day One - Track Three
Presenter Q+A & Audience Discussion 12:00 pm
day: Conference Day One - Track Three